Biostent cytochalasin B: Will start in March a Phase I safety trial of four different doses and placebo, in 40 angioplasty patients

NeoRx Corp. (NERX), Seattle
Product:

Read the full 51 word article

How to gain access

Continue reading with a
two-week free trial.